echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > JGH: The incidence of COVID-19 infection is low in patients with inflammatory bowel disease treated with non-intestinal selective biological therapy

    JGH: The incidence of COVID-19 infection is low in patients with inflammatory bowel disease treated with non-intestinal selective biological therapy

    • Last Update: 2021-12-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Since the outbreak of the new coronary pneumonia pandemic caused by the Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Italy has been one of the earliest and most severely affected countries


    Since the outbreak of the new coronary pneumonia pandemic caused by the Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Italy has been one of the earliest and most severely affected countries


     

    This observational retrospective multicenter study collected COVID-19 data on IBD patients who received biological therapy in Italy from February 2020 to May 2020


     

    The results of the study showed that among 1816 IBD patients, the cumulative incidence of COVID-19 was 3.


     

    This study confirms that compared with the general population, IBD patients receiving biological therapy do not have a higher risk of COVID-19


    This study confirms that compared with the general population, IBD patients receiving biological therapy do not have a higher risk of COVID-19


    Sandro Ardizzone.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.